Barclays plc Stock
Your prediction
Barclays plc Stock
Barclays plc shows a slight decrease today, losing -€0.019 (-0.310%) compared to yesterday.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Barclays plc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Barclays plc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Cons
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Barclays plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Barclays plc | -0.310% | 1.878% | 3.280% | 41.655% | 11.097% | 248.093% | 179.917% |
| Standard Chartered plc | 1.530% | 1.393% | 8.130% | 63.750% | 22.430% | 200.528% | 389.720% |
| HSBC Holdings plc | -0.620% | -2.768% | 7.031% | 65.027% | 33.338% | 140.720% | 276.910% |
| NatWest Group plc | -1.190% | 2.659% | 9.270% | 38.148% | 12.303% | 200.036% | 207.917% |
Comments
News
ZipRecruiter Q2 Earnings Call Highlights
Key Points
- Interested in ZipRecruiter, Inc.? Here are five stocks we like better.
- Second-quarter results exceeded expectations: Revenue rose 5% year over year to $118.1 million, while adjusted
1 Top Wall Street Analyst Thinks This Stock Could Soar 95% Over the Next 12 Months. Here's Why I Agree.
BridgeBio Pharma (NASDAQ: BBIO) has already been one of biotech's biggest winners over the past two years (up 209% as of July 31). Yet Barclays analyst Eliana Merle believes the rally may not be
Frontier Group Q2 Earnings Call Highlights
Key Points
- Interested in Frontier Group Holdings, Inc.? Here are five stocks we like better.
- Frontier’s second-quarter results exceeded expectations: Revenue reached a record $1.3 billion, up